drugset / Trial / NCT06908694
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
Phase 4
Active not recruiting
20 enrolled
Hamilton Health Sciences Corporation
McMaster University · collab
NaSingle-groupOpen-labelTreatment
Summary
GAIN PC CONTROL is a study investigating Glucagon-Like Peptide-1 Receptor Agonists in men with prostate cancer who are being treated with androgen deprivation therapy.
Timeline
- Start
- 2025-07-02
- Primary completion
- 2027-10-31
- Completion
- 2027-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | 2.4 mg | Subcutaneous |